Genetic modulation of plasma NPY stress response is suppressed in substance abuse: Association with clinical outcomes

Psychoneuroendocrinology

Volumn 37, Issue 4, 2012, Pages 554-564

  Xu, Ke ^a   Hong, Kwangik Adam ^a   Zhou, Zhifeng ^c   Hauger, Richard L ^d   Goldman, David ^c   Sinha, Rajita ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Functional haplotype; Neuropeptide Y; Stress; Substance use disorders

Indexed keywords

NEUROPEPTIDE Y;

ADULT; ALCOHOLISM; ANXIETY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GUIDED IMAGERY; HAPLOTYPE; HEART RATE VARIABILITY; HUMAN; MALE; NEUROMODULATION; NEUROPEPTIDE Y GENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; RELAXATION TRAINING; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SUBSTANCE ABUSE;

ADULT; ANXIETY; CASE-CONTROL STUDIES; CUES; FEMALE; HAPLOTYPES; HEART RATE; HUMANS; IMAGERY (PSYCHOTHERAPY); MALE; MIDDLE AGED; NEUROPEPTIDE Y; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 84857192445     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.08.005     Document Type: Article

References (65)

1. Allen R., Boublik J., Hauger R., Scott H., Rivier J., Brown M.B. Neuropeptide Y radioimmunoassay: characterization and application. Clin. Exp. Pharmacol. Physiol. 1991, 18:825-833.
2. Bar K.J., Boettger M.K., Neubauer R., Groteluschen M., Jochum T., Baier V., Sauer H., Voss A. Heart rate variability and sympathetic skin response in male patients suffering from acute alcohol withdrawal syndrome. Alcohol. Clin. Exp. Res. 2006, 30:1592-1598.
3. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharmacol. 1995, 6:215-222.
4. Chaplin T.M., Hong K., Bergquist K., Sinha R. Gender differences in response to emotional stress: an assessment across subjective, behavioral, and physiological domains and relations to alcohol craving. Alcohol. Clin. Exp. Res. 2008, 32:1242-1250.
5. Chronwall B.M., DiMaggio D.A., Massari V.J., Pickel V.M., Ruggiero D.A., O'Donohue T.L. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 1985, 15:1159-1181.
6. Cohen J. Statistical Power Analysis for Behavioral Sciences 1988, Lawrence Erlbaum Associates, New Jersey. 2nd edition.
7. Colzato L.S., van den Wildenberg W.P., Van der Does A.J., Hommel B. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 2010, 170(October (3)):782-788. (Epub. 1 August 2010).
8. First M., Spitzer R., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV 1995, American Psychiatric Press Inc, Washington DC. Patient Edition.
9. Fox H.C., Bergquist K.L., Hong K.I., Sinha R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol dependent individuals. Alcohol. Clin. Exp. Res. 2007, 31:395-403.
10. Fox H.C., Hong K.I., Siedlarz K., Sinha R. Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers. Neuropsychopharmacology 2008, 33:796-805.
11. Gehlert D.R. Introduction to the reviews on neuropeptide Y. Neuropeptides 2004, 38:135-140.
12. Gilpin N.W., Stewart R.B., Badia-Elder N.E. Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats. Alcohol 2008, 42:541-551.
13. Goldman D. Candidate genes in alcoholism. Clin. Neurosci. 1995, 3:174-181.
14. Goldman D., Oroszi G., Ducci F. The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 2005, 6:521-532.
15. Hariri A.R., Mattay V.S., Tessitore A., Kolachana B., Fera F., Goldman D., Egan M.F., Weinberger D.R. Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297(July (5580)):400-403.
16. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004, 38:213-224.
17. Heilig M., Soderpalm B., Engel J.A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl.) 1989, 98:524-529.
18. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol. Clin. Exp. Res. 2005, 29:8-16.
19. Ingjaldsson J.T., Laberg J.C., Thayer J.F. Reduced heart rate variability in chronic alcohol abuse: relationship with negative mood, chronic thought suppression, and compulsive drinking. Biol. Psychiatry 2003, 54:1427-1436.
20. Izard C. Patterns of Emotions: A New Analysis of Anxiety and Depression 1972, Academic Press, New York.
21. Karl T., Duffy L., Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur. J. Neurosci. 2008, 28:173-180.
22. Kauhanen J., Karvonen M., Pesonen U., Koulu M., Tuomainen T., Uusitupa M., Salonen J. Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am. J. Med. Genet. 2000, 93:117-121.
23. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
24. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 2004, 27:739-749.
25. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005, 8:1450-1457.
26. Krysiak R., Obuchowicz E., Herman Z.S. Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. Eur. J. Endocrinol. 1999, 140:130-136.
27. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
28. Lang P.J., Kozak M.J., Miller G.A., Levin D.N., McLean A. Emotional imagery: conceptual structure and pattern of somatovisceral response. Psychophysiology 1980, 17:179-192.
29. Lappalainen J., Kranzler H.R., Malison R., Price L.H., Van Dyck C., Rosenheck R.A., Cramer J., Southwick S., Charney D., Krystal J., Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 2002, 59:825-831.
30. Lindell S.G., Schwandt M.L., Sun H., Sparenborg J.D., Björk K., Kasckow J.W., Sommer W.H., Goldman D., Higley J.D., Suomi S.J., Heilig M., Barr C.S. Functional NPY variation as a factor in stress resilience and alcohol consumption in rhesus macaques. Arch. Gen. Psychiatry 2010, 67(April (4)):423-431.
31. Majewska M.D. HPA axis and stimulant dependence: an enigmatic relationship. Psychoneuroendocrinology 2002, 27:5-12.
32. Maric T., Cantor A., Cuccioletta H., Tobin S., Shalev U. Neuropeptide Y augments cocaine self-administration and cocaine-induced hyperlocomotion in rats. Peptides 2008, 30:721-726.
33. Maric T., Tobin S., Quinn T., Shalev U. Food deprivation-like effects of neuropeptide Y on heroin self-administration and reinstatement of heroin seeking in rats. Behav. Brain Res. 2008, 194:39-43.
34. Mickey B.J., Zhou Z., Heitzeg M.M., Heinz E., Hodgkinson C.A., Hsu D.T., Langenecker S.A., Love T.M., Peciña M., Shafir T., Stohler C.S., Goldman D., Zubieta J.K. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch. Gen. Psychiatry 2011, 68(February (2)):158-166.
35. Mottagui-Tabar S., Prince J.A., Wahlestedt C., Zhu G., Goldman D., Heilig M. A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol. Clin. Exp. Res. 2005, 29:702-707.
36. Olling J.D., Ulrichsen J., Haugbol S., Glenthoj B., Hemmingsen R., Woldbye D.P. Decreased gene expression of neuropeptide Y and its receptors in hippocampal regions during ethanol withdrawal in rats. Neurosci. Lett. 2007, 424:160-164.
37. Paliwal P., Hyman S.M., Sinha R. Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 2008, 93:252-259.
38. Pandey S.C., Roy A., Zhang H., Xu T. Partial deletion of the cAMP response element-binding protein gene promotes alcohol-drinking behaviors. J. Neurosci. 2004, 24:5022-5030.
39. Pandey S.C., Ugale R., Zhang H., Tang L., Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. J. Neurosci. 2008, 28:3729-3737.
40. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8(June (6)):828-834. (Epub. 8 May 2005).
41. Prakash A., Zhang H., Pandey S.C. Innate differences in the expression of brain-derived neurotrophic factor in the regions within the extended amygdala between alcohol preferring and nonpreferring rats. Alcohol. Clin. Exp. Res. 2008, 32:909-920.
42. Rasmusson A.M., Hauger R.L., Morgan C.A., Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol. Psychiatry 2000, 47:526-539.
43. Rasmusson A.M., Southwick S.M., Hauger R.L., Charney D.S. Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology 1998, 19:95-98.
44. Renthal W., Nestler E. Epigenetic mechanisms in drug addiction. Trends Mol. Med. 2008, 14:341-350.
45. Sajdyk T.J., Johnson P.L., Leitermann R.J., Fitz S.D., Dietrich A., Morin M., Gehlert D.R., Urban J.H., Shekhar A. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J. Neurosci. 2008, 28:893-903.
46. Scheurich A., Muller M.J., Anghelescu I., Lorch B., Dreher M., Hautzinger M., Szegedi A. Reliability and validity of the form 90 interview. Eur. Addict. Res. 2005, 11:50-56.
47. Shi J., Li S.X., Zhang X.L., Wang X., Le Foll B., Zhang X.Y., Kosten T.R., Lu L. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. Am. J. Drug Alcohol Abuse 2009, 35(5):267-272.
48. Sinha R., Lovallo W.R., Parsons O.A. Cardiovascular differentiation of emotions. Psychosom. Med. 1992, 54:422-435.
49. Sinha R., Parsons O.A. Multivariate response patterning of fear and anger. Cogn. Emot. 1996, 10:173-198.
50. Sinha R., Catapano D., O'Malley S.S. Stress-induced craving and stress responses in cocaine dependent individuals. Psychopharmacology (Berl.) 1999, 142:343-351.
51. Sinha R., Talih M., Malison R., Anderson G.A., Cooney N., Kreek M. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl.) 2003, 170:62-72.
52. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 2008, 1141:105-130.
53. Sinha R., Fox H.C., Hong K.A., Bergquist K., Bhagwagar Z., Siedlarz K.M. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009, 34:1198-1208.
54. Sinha R., Garcia M., Paliwal P., Kreek M.J., Rounsaville B.J. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch. Gen. Psychiatry 2006, 63:324-331.
55. Sinha R. Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict. Biol. 2009, 14:84-98.
56. Sinha R. The role of stress in addiction relapse. Curr. Psychiatry Rep. 2007, 9:388-395.
57. Thiele T.E., Marsh D.J., Ste Marie L., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998, 396:366-369.
58. Thorsell A., Carlsson K., Ekman R., Heilig M. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 1999, 10:3003-3007.
59. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathe A.A., Heilig M. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12852-12857.
60. Walter M., Gerhard U., Gerlach M., Weijers H.G., Boening J., Wiesbeck G.A. Cortisol concentrations, stress-coping styles after withdrawal and long-term abstinence in alcohol dependence. Addict. Biol. 2006, 11:157-162.
61. Westrin A., Ekman R., Traskman-Bendz L. Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt. Eur. Neuropsychopharmacol. 1999, 9:205-211.
62. Woldbye D.P., Nanobashvili A., Husum H., Bolwig T.G., Kokaia M. Neuropeptide Y inhibits in vitro epileptiform activity in the entorhinal cortex of mice. Neurosci. Lett. 2002, 333:127-130.
63. Zhou Z., Zhu G., Hariri A.R., Enoch M.A., Scott D., Sinha R., Virkkunen M., Mash D.C., Lipsky R.H., Hu X.Z., Hodgkinson C.A., Xu K., Buzas B., Yuan Q., Shen P.H., Ferrell R.E., Manuck S.B., Brown S.M., Hauger R.L., Stohler C.S., Zubieta J.K., Goldman D. Genetic variation in human NPY expression affects stress response and emotion. Nature 2008, 452:997-1001.
64. Zhu G., Pollak L., Mottagui-Tabar S., Wahlestedt C., Taubman J., Virkkunen M., Goldman D., Heilig M. NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations. Alcohol. Clin. Exp. Res. 2003, 27:19-24.
65. Zill P., Pruess U.W., Koller G., Bondy B., Soyka M. Analysis of single nucleotide polymorphisms and haplotypes in the neuropeptide Y gene: no evidence for association with alcoholism in a German population sample. Alcohol. Clin. Exp. Res. 2008, 32:430-434.